Kao Chung Tsai

Kao Chung Tsai currently works at Sonix Technology Co., Ltd., as Independent Director from 2004, Microbio Co., Ltd., as Independent Director from 2006, Holy Stone Healthcare Co., Ltd., as Independent Director from 2014, GlycoNex, Inc., as Director, Double Bond Chemical Ind., Co., Ltd., as Independent Director from 2016, Nuvision Technology, Inc., as Member-Supervisory Board, and Diamond BioFund Inc, as Member-Supervisory Board.
Mr. Tsai also formerly worked at Champion Microelectronic Corp., as Chairman, Advanced Optoelectronic Technology, Inc., as Independent Director, SYNCOMM Technology Corp., as Director, HIGGSTEC, INC., as Independent Director, Original BioMedicals Co., Ltd., as Director, WT Microelectronics Co., Ltd., as Member-Supervisory Board from 2007 to 2016, Taiwan International Securities Corp., as Deputy General Manager-Underwriting Department, Solytech Enterprise Corp., as Member-Supervisory Board from 2009 to 2021, UltraChip, Inc., as Member-Supervisory Board, and Barits Securities Corp., as Deputy general Manager-Underwriting Department.
Mr. Tsai received his graduate degree from Soochow University.